SPA
EVH icon

Sherbrooke Park Advisers’s Evolent Health EVH Stock Holding History

Sherbrooke Park Advisers’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$86.8K Buy
+21,696
New +$121K 0.22% 136
2024
Q3 		– Sell
-23,978
Closed -$458K – 997
2024
Q2 		$458K Buy
23,978
+5,341
+29% +$136K 0.08% 452
2024
Q1 		$611K Buy
+18,637
New +$595K 0.12% 300

Other funds holding EVH

CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sherbrooke Park Advisers's EVH Position: Q4 2025 in Review

Sherbrooke Park Advisers opened a new position in Evolent Health (EVH) in Q4 2025: 21,696 shares worth $86.8K. The stake represents 0.22% of the portfolio and ranks #136 among its holdings. This is a return to the name: Sherbrooke Park Advisers previously reported a position in EVH as recently as Q2 2024.

Sherbrooke Park Advisers first reported a position in EVH in Q1 2024 and has held it in 3 quarters since. The position peaked at $611K in Q1 2024. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Sherbrooke Park Advisers held 21,696 shares of Evolent Health worth $86.8K as of Q4 2025.
  • Evolent Health was a new Sherbrooke Park Advisers position in Q4 2025.
  • Evolent Health made up 0.22% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #136 holding.
  • Sherbrooke Park Advisers first reported a position in Evolent Health in Q1 2024 and has held it in 3 quarters since.
  • Sherbrooke Park Advisers's Evolent Health position peaked at $611K in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.